The Scientist

» industry and cell & molecular biology

Most Recent

image: Another Gene-Editing IPO

Another Gene-Editing IPO

By | April 12, 2016

Intellia Therapeutics, which seeks to develop CRISPR-based technologies to target rare diseases, is hoping to raise $120 million in an initial public offering.

0 Comments

image: Pfizer-Allergan Merger Scrapped

Pfizer-Allergan Merger Scrapped

By | April 7, 2016

A move by the US federal government to close tax loopholes that encourage “tax inversions” likely spooked the companies out of the multibillion dollar deal.

0 Comments

image: Zooming In on an Antidepressant Target

Zooming In on an Antidepressant Target

By | April 6, 2016

Structural studies reveal how SSRI drugs bind to the human serotonin transporter.

0 Comments

image: New Epigenetic Mark Confirmed in Mammals

New Epigenetic Mark Confirmed in Mammals

By | April 1, 2016

Methylation on adenine bases is involved in the dampening of gene expression in mammalian cells, according to a study.

0 Comments

image: Cancer's Vanguard

Cancer's Vanguard

By | April 1, 2016

Exosomes are emerging as key players in metastasis.

0 Comments

image: Cancerous Conduits

Cancerous Conduits

By | April 1, 2016

Metastatic cancer cells use nanotubes to manipulate blood vessels.

0 Comments

image: Tumor Traps

Tumor Traps

By | April 1, 2016

After surgery to remove a tumor, neutrophils recruited to the site spit out sticky webs of DNA that aid cancer recurrence.

0 Comments

image: A Different Way of Doing Things

A Different Way of Doing Things

By | April 1, 2016

Cancer cells exhibit altered metabolic processes that may serve as promising targets for new therapies.

0 Comments

image: Metabolic Reprogramming

Metabolic Reprogramming

By | April 1, 2016

How cancer cells fuel their rapid growth

0 Comments

image: The Forces of Cancer

The Forces of Cancer

By | April 1, 2016

A tumor’s physical environment fuels its growth and causes treatment resistance.

0 Comments

Popular Now

  1. Broad Wins CRISPR Patent Interference Case
    Daily News Broad Wins CRISPR Patent Interference Case

    The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.

  2. Henrietta Lacks’s Family Seeks Compensation
  3. Can Plants Learn to Associate Stimuli with Reward?
  4. Humans Never Stopped Evolving
    Features Humans Never Stopped Evolving

    The emergence of blood abnormalities, an adult ability to digest milk, and changes in our physical appearance point to the continued evolution of the human race.

Business Birmingham